Nasdaq
ZYBT
Zhengye Biotechnology Holding Limited
- Health Care
- China
- Listed 2025
- 1 day
- −11.4%
- 1 month
- +172%
- 1 year
- −61.7%
$2.09 · Mkt cap $99.0M · P/E 69.67
At the 6 Aug 2026 close
Nasdaq
Zhengye Biotechnology Holding Limited
$2.09 · Mkt cap $99.0M · P/E 69.67
At the 6 Aug 2026 close
Zhengye Biotechnology Holding Limited trades under the ticker ZYBT on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2025. Its market capitalisation is $99.0M. The last closing price was $2.09, on 6 Aug 2026. It trades at 69.67 times its last reported annual diluted earnings per share. Over the past year the share price is −61.7%, and +172% over the past month. Returns are price returns and exclude dividends.
This page exists because ZYBT is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.